Who has invested in LevitasBio?

Novalis Lifesciences, Pavilion Capital, Decheng Capital are named among the investors backing LevitasBio.

LevitasBio Funding: $70M Raised, Series C (2022)

LevitasBio funding overview

LevitasBio is based in Menlo Park, CA. LevitasBio has raised $70M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in November 2022. The round record for LevitasBio runs through 2022; nothing later has been disclosed. Investors on record include Novalis Lifesciences, Pavilion Capital, Decheng Capital. 3 distinct backers are named across the disclosed rounds.

LevitasBio at a glance

Total raised: $70M
Latest round: Series C
Latest round date: November 2022
Headquarters: Menlo Park, CA
Notable investors: Novalis Lifesciences, Pavilion Capital, Decheng Capital

Frequently asked about LevitasBio funding

How much has LevitasBio raised?: LevitasBio has raised $70M in total disclosed funding across the rounds on record.
Who has invested in LevitasBio?: Novalis Lifesciences, Pavilion Capital, Decheng Capital are named among the investors backing LevitasBio.
What was the latest LevitasBio funding round?: The most recent disclosed round is a Series C, announced in November 2022.
Where is LevitasBio based?: LevitasBio is based in Menlo Park, CA.
When did LevitasBio last raise?: The last disclosed LevitasBio round closed in November 2022 at Series C.

LevitasBio totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Menlo Park below to benchmark round size and investor mix.

LevitasBio Funding: $70M Raised, Series C (2022)

LevitasBio funding overview

LevitasBio at a glance

Frequently asked about LevitasBio funding

Companies related to LevitasBio (18)

Browse related funding lists (5)